CDC releases recommendations to prevent staph infections in neonatal ICUs
The Centers for Disease Control and Prevention has released evidence-based recommendations to prevent and control Staphylococcus aureus in neonatal intensive care units, including strains resistant (MRSA) or sensitive (MSSA) to the antibiotic methicillin.
The recommendations supplement existing CDC recommendations for all health care settings based on a systematic review of the best available literature, the agency said.
“While MRSA has long been the focus of prevention efforts due to the difficulty in treating and eradicating it, recent studies have demonstrated that methicillin-sensitive S. aureus (MSSA) has morbidity and mortality equal to MRSA and occurs more frequently in NICU patients,” the guidelines note.
Related News Articles
Headline
Rural hospital leaders recently shared strategies and insights on improving safety culture, governance and care reliability at the AHA’s Rural Patient Safety…
Blog
Rural hospital leaders from across the country came together to share strategies and insights for improving safety culture, governance and care…
Headline
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier…
Blog
Cross-industry insights and new technology are helping HCA Healthcare reduce risk, improve outcomes and lead the future of high-reliability careFor Randy Fagin…
Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…